Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.

The cancer therapy developer and Jackson Laboratory spinout floated at the upper end of its range and now has a $600m market cap.

University of Ulm spinout WITec has agreed to a $50m acquisition by Oxford Instruments, itself the first-ever spinout of University of Oxford.

Broad Institute and UPenn-linked cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

The solid-state battery maker will get a Nasdaq listing through the deal, which follows $161m in funding the company raised since being spun out of CU Boulder.

Metacon has acquired all outstanding shares in its existing portfolio company Helbio, which was spun out of University of Patras two decades ago.

StartX-backed UnifyID has agreed to an acquisition by Prove for an undisclosed amount.

Agilio Software has bought Newcastle spinout Clarity Informatics, a healthtech developer founded in 2000.

Noria Therapeutics and PSMA Therapeutics have both been acquired by Bayer, which will integrate their respective assets into its own oncology portfolio.

IP Group sold a $5m stake to incoming shareholder Celltrion as part of a series A round for Iksuda, a spinout of Bath originally called Glythera.